The Journal of Prevention of Alzheimer's Disease
Издатель: Elsevier · ISSN 2274-5807 · 44 статей
- Autopsy findings in Alzheimer's disease clinical trial participants demonstrate a high frequency of off-target coexisting pathologic features
- Evoke (+) trials of semaglutide for early alzheimer’s disease: Innovations, lessons, and implications
- Feasibility of immersive 40 Hz gamma sensory stimulation in early-stage Alzheimer’s disease
- Pharmacological interventions for reducing the risk of cognitive decline and dementia after stroke/transient ischemic attack: A systematic review
- Estimating the eligible population for amyloid-targeting monoclonal antibody therapy in memory clinics: Application to lecanemab in France
- Updated Italian intersocietal recommendations for the appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease
- Baseline MRI markers and clinical outcomes during anti-amyloid β therapy: A real-world study in a Japanese dementia center
- Cerebral microhemorrhage and cognition in preclinical Alzheimer’s disease
- Linguistic features from constrained spontaneous speech as potential markers of preclinical Alzheimer’s disease
- CSF pTau181 predicts asymmetric hippocampal atrophy in cognitively unimpaired older adults
- Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes
- Efficacy and safety of anti-tau drugs for Alzheimer’s disease: A systematic review and network meta-analysis
- Survival analysis of spontaneous speech for predicting mild cognitive impairment-to-dementia conversion
- Considering evoke and evoke+ outcomes for future Alzheimer’s disease drug development